Mehmet Bilen, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Gene Therapy Pain Management Targeted Therapy
Hacettepe University Faculty of Medicine
Medical School
Baylor College of Medicine
Residency
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
GA State Medical License Active through 2017
Southern Regional Medical Center
Languages: English/Spanish
(770) 991-8000
11 Upper Riverdale Rd,
Read MoreSafety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin.
Bilen MA, Cauley DH, Atkinson BJ, Chen H, Kaya DH, Wang X, Vikram R, Tu S, Corn PG, Kim J; Clin Genitourin Cancer. 2016-12-13.
See more >>Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang M, Naing A, General R, Cauley DH, Lin S, Logothetis CJ, Pisters ...; Oncotarget. 2016-11-16.
See more >>Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
Bilen MA, Patel A, Hess KR, Munoz J, Busaidy NL, Wheler JJ, Janku F, Falchook GS, Hong DS, Meric-Bernstam F, Habra MA, Naing A; Cancer Chemother. Pharmacol.. 2016-07-01.
See more >>